BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong C, Dang D, Zhao X, Wang Y, Wang Z, Zhang C. Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis. Front Immunol 2021;12:713001. [PMID: 34733272 DOI: 10.3389/fimmu.2021.713001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Y, Yao J, Fang Q, Chen B, Zang G. A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Aging 2022. [DOI: 10.18632/aging.204411] [Reference Citation Analysis]
2 Zhang C, Dang D, Wang H, Shi S, Dai J, Yang M. Acircadian rhythm-related gene signature for predicting survival and drug response in HNSC. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1029676] [Reference Citation Analysis]
3 Xie Y, Xu Z, Mei X, Shi W. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/8232024] [Reference Citation Analysis]
4 Zhen J, Ke Y, Pan J, Zhou M, Zeng H, Song G, Yu Z, Fu B, Liu Y, Huang D, Wu H. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle. Aging 2022. [DOI: 10.18632/aging.204350] [Reference Citation Analysis]
5 Liu J, Liu L, Li Z, Luo Y, Liang F. The role of cuproptosis-related gene in the classification and prognosis of melanoma. Front Immunol 2022;13:986214. [DOI: 10.3389/fimmu.2022.986214] [Reference Citation Analysis]
6 Liu J, Tan Z, Yang S, Song X, Li W. A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma. Aging. [DOI: 10.18632/aging.204288] [Reference Citation Analysis]
7 Ning Y, Lin K, Liu X, Ding Y, Jiang X, Zhang Z, Xuan Y, Dong L, Liu L, Wang F, Zhao Q, Wang H, Fang J. NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02475-8] [Reference Citation Analysis]
8 Yu L, Liu X, Wang X, Yan H, Pu Q, Xie Y, Du J, Yang Z. Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy. Front Cell Dev Biol 2022;10:940551. [DOI: 10.3389/fcell.2022.940551] [Cited by in F6Publishing: 1] [Reference Citation Analysis]